184 related articles for article (PubMed ID: 8858533)
1. Chemotherapy for meningiomas.
Kyritsis AP
J Neurooncol; 1996 Sep; 29(3):269-72. PubMed ID: 8858533
[TBL] [Abstract][Full Text] [Related]
2. Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.
Ji Y; Rankin C; Grunberg S; Sherrod AE; Ahmadi J; Townsend JJ; Feun LG; Fredericks RK; Russell CA; Kabbinavar FF; Stelzer KJ; Schott A; Verschraegen C
J Clin Oncol; 2015 Dec; 33(34):4093-8. PubMed ID: 26527781
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
Mason WP; Gentili F; Macdonald DR; Hariharan S; Cruz CR; Abrey LE
J Neurosurg; 2002 Aug; 97(2):341-6. PubMed ID: 12186462
[TBL] [Abstract][Full Text] [Related]
4. Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro.
Ragel BT; Gillespie DL; Kushnir V; Polevaya N; Kelly D; Jensen RL
Neurosurgery; 2006 Nov; 59(5):1109-20; discussion 1120-1. PubMed ID: 17143245
[TBL] [Abstract][Full Text] [Related]
5. Treatment for rare brain tumors veers from traditional tack.
McBride G
J Natl Cancer Inst; 1997 Jul; 89(13):912-3. PubMed ID: 9214668
[No Abstract] [Full Text] [Related]
6. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
Schrell UM; Rittig MG; Anders M; Koch UH; Marschalek R; Kiesewetter F; Fahlbusch R
J Neurosurg; 1997 May; 86(5):840-4. PubMed ID: 9126900
[TBL] [Abstract][Full Text] [Related]
7. Mifepristone (RU 486) treatment of meningiomas.
Lamberts SW; Tanghe HL; Avezaat CJ; Braakman R; Wijngaarde R; Koper JW; de Jong H
J Neurol Neurosurg Psychiatry; 1992 Jun; 55(6):486-90. PubMed ID: 1619417
[TBL] [Abstract][Full Text] [Related]
8. Intracerebral Meningiomas.
Chamberlain MC
Curr Treat Options Neurol; 2004 Jul; 6(4):297-305. PubMed ID: 15157407
[TBL] [Abstract][Full Text] [Related]
9. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone.
Grunberg SM; Weiss MH; Spitz IM; Ahmadi J; Sadun A; Russell CA; Lucci L; Stevenson LL
J Neurosurg; 1991 Jun; 74(6):861-6. PubMed ID: 2033444
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
Mazza E; Brandes A; Zanon S; Eoli M; Lombardi G; Faedi M; Franceschi E; Reni M
Cancer Chemother Pharmacol; 2016 Jan; 77(1):115-20. PubMed ID: 26659583
[TBL] [Abstract][Full Text] [Related]
11. Meningiomas.
Chamberlain MC
Curr Treat Options Neurol; 2001 Jan; 3(1):67-76. PubMed ID: 11123860
[TBL] [Abstract][Full Text] [Related]
12. A successful case of an anaplastic meningioma treated with chemotherapy for soft tissue sarcomas.
Lucchesi M; Buccoliero AM; Scoccianti S; Guidi M; Farina S; Fonte C; Favre C; Genitori L; Sardi I
CNS Oncol; 2016 Jul; 5(3):131-6. PubMed ID: 27226409
[TBL] [Abstract][Full Text] [Related]
13. The role of mifepristone in the management of meningiomas: A systematic review of literature.
Sharma R; Garg K; Katiyar V; Tandon V; Agarwal D; Singh M; Chandra SP; Suri A; Kale SS; Mahapatra AK
Neurol India; 2019; 67(3):698-705. PubMed ID: 31347538
[TBL] [Abstract][Full Text] [Related]
14. The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B.
Kaba SE; DeMonte F; Bruner JM; Kyritsis AP; Jaeckle KA; Levin V; Yung WK
Neurosurgery; 1997 Feb; 40(2):271-5. PubMed ID: 9007858
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea chemotherapy in the treatment of meningiomas.
Newton HB
Neurosurg Focus; 2007; 23(4):E11. PubMed ID: 17961035
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas.
Chamberlain MC; Glantz MJ
Cancer; 2008 Oct; 113(8):2146-51. PubMed ID: 18756531
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
[TBL] [Abstract][Full Text] [Related]
18. Temozolomide for recurrent meningiomas: a case-report with unexpected clinical and radiological response.
Pellerino A; Soffietti R; Rudà R
J Neurooncol; 2016 Mar; 127(1):201-3. PubMed ID: 26614515
[No Abstract] [Full Text] [Related]
19. Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas.
Sioka C; Kyritsis AP
J Neurooncol; 2009 Mar; 92(1):1-6. PubMed ID: 19023520
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo.
Matsuda Y; Kawamoto K; Kiya K; Kurisu K; Sugiyama K; Uozumi T
J Neurosurg; 1994 Mar; 80(3):527-34. PubMed ID: 8113866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
